Sepracor&#39;s Dream Drug?
65963
Sepracor (Nasdaq: SEPR) scored a major victory yesterday, though investors should have their eyes wide open when considering the stock.
640990
Now might be a great time to load up on cutting-edge drug makers.
323940
First it was antidepressants. Then Vioxx. Now questions have been raised about the safety of yet another drug, the painkiller Bextra, made by Pfizer (PFE ). Is there anything you can do to prevent the unnerving
136421
Millions of Americans have done just that. Thanks to them, a class of pain relievers called COX-2 inhibitors - Pfizer&#39;s Celebrex and Bextra, and Merck&#39;s Vioxx - have become blockbusters.
742333
Sepracor Inc., a specialty  pharmaceutical company, said on Wednesday it received a  long-awaited approval to market its Lunesta treatment for  insomnia, giving it a foothold in an estimated $2 billion  market in the United States.
138698
Another schizophrenia drug from the company shows promise in a clinical trial.
232912
It would seem a drug executive&#39;s dream come true. A week ago Thursday, the secretary of health and human services summoned the top officials of MedImmune to his office in Washington to ask
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
358115
Tekturna, the first new type of blood pressure medicine in more than a decade, is a potential blockbuster for the Swiss pharmaceutical maker Novartis.
187991
Investors and insomniacs can rest easy: The Food &amp; Drug Administration approved Lunesta, Sepracor&#39;s (SEPR ) new drug for sleeplessness, on Dec. 15.
615158
A NEW &quot;miracle&quot; drug for obesity could prove central to the fortunes of manufacturer Sanofi-Aventis, if the French company is successful in bringing it to the market.
591115
A one-drug wonder doesn't have a future.
20994
Pfizer plans to ask or approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.
243349
This lung cancer drug is not as effective as once hoped.
614122
Sepracor and GlaxoSmithKline ink a deal to market Lunesta worldwide.
610018
New technology could lead to safer, more effective drugs.
264861
Osteoporosis drug could give the company its next big winner.